Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Checked against the public recordLast updated Jun 25, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- OHSU Knight Cancer Institute
- Interventions being studied
- Other: Best Practice; Other: Health Promotion and Education; Other: Questionnaire Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * AIM 1: Suspected lung cancer * AIM 1: English fluency * AIM 1: \> 6-month life expectancy * AIM 1: Score of ≥ 3 on the cognitive impairment screener * AIM 2 PARTICIPANTS: Participation in Aim 1 * AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Hillsboro Medical CenterHillsboro, Oregon
- Adventist Health PortlandPortland, Oregon
- OHSU Knight Cancer InstitutePortland, Oregon
- Portland VA Medical CenterPortland, Oregon
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 25, 2026. Always confirm current availability with the study team.